Table 2.
Taurine concentration in tissues and plasma following taurine supplementation for 3 weeks. Values are mean ± SD.
| Tissue | 3wCon/Sed | 3wTau/Sed | 3wCon/Exe | 3wTau/Exe | |
|---|---|---|---|---|---|
| GC-W | (nmol·mg-1) | 13.8 (.3) | 21.0 (.3) ‡ | 14.1 (.3) | 20.1 (.3) ‡* |
| GC-R | (nmol·mg-1) | 21.4 (.7) | 29.0 (.7) ‡ | 21.7 (.7) | 27.8 (.7) ‡ |
| Plantaris | (nmol·mg-1) | 18.3 (.6) | 24.0 (.6) ‡ | 17.8 (0.6) | 23.3 (.6) ‡ |
| Liver | (nmol·mg-1) | 2.1 (1.8) | 17.9 (1.8) ‡ | 5.0 (2.0) | 13.2 (1.8) ‡ |
| Plasma | (nmol·mg-1) | 326 (288) | 876 (561) ‡ | 481 (396) | 1201 (430) ‡ |
Footnote:
‡, p < 0.01 for the significant difference to the respective non-supplemented control group by two-way ANOVA.
*, p < 0.05 for the significant difference to the 3wTau/Sed group by two-way ANOVA followed by Bonferroni’s post hoc analysis.
Abbreviations: 3wCon/Sed; three-week non-supplemented and sedentary group, 3wTau/Sed; three-week taurine-supplemented and sedentary group, 3wCon/Exe; three-week non-supplemented and exercised group, 3wCon/Exe; three-week taurine-supplemented and exercised group, and see the footnote of Table 1 for other abbreviations.